M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.

Abstract

There are no Food and Drug Administration approved pharmacotherapies for methamphetamine (METH) overdose, thus identifying novel drug targets to prevent this devastating adverse event is a public-health imperative. Previous research suggests that serotonin and sigma receptors may contribute to the adverse effects of METH. The present study assessed whether pretreatment with the 5-HT2A receptor antagonist M100907 or the sigma 1 (σ1) receptor antagonist BD 1047 attenuated METH-induced lethality, hyperthermia, convulsions, and seizures. Male, Swiss-Webster mice received intraperitoneal injections of M100907 (1 and 10 mg/kg), BD 1047 (10 mg/kg), or a combination of M100907 (1 mg/kg) and BD 1047 (10 mg/kg) prior to treatment with METH (78 mg/kg). Convulsions and lethality were assessed by observation, core body temperature was assessed by surgically implanted telemetric probes, and seizures were assessed by electroencephalography. M100907 reduced METH-elicited lethality from 67% to 33%, BD1047 reduced METH-elicited lethality from 67% to 50%, and combined administration of both agents eliminated lethality in all mice tested. Similarly, both agents and their combination reduced METH-elicited seizures and convulsions. None of the treatments decreased METH-induced hyperthermia. This research suggests that reducing METH-induced seizures is an important factor in reducing lethality associated with METH overdose. However, future studies should examine whether M100907 and BD 1047 modulate METH-induced hypertension and other adverse effects that may also contribute to METH overdose. Our data support the continued investigation of compounds that target 5-HT2A and σ1 receptors in METH-induced overdose, including their potential to yield emergency reversal agents.

• Authors: Azizi Ray, Clinton E Canal, J Christopher Ehlen, Kenner C Rice, Kevin Sean Murnane
• Journal: Neurotoxicology (Neurotoxicology) Vol. 74 Pg. 91-99 (09 2019) ISSN: 1872-9711 [Electronic] Netherlands
• PMID: 31163210 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural)
• Copyright: Copyright © 2019 Elsevier B.V. All rights reserved.

Chemical References

• Central Nervous System Stimulants
• Ethylenediamines
• Fluorobenzenes
• Piperidines
• Receptors, sigma
• Serotonin 5-HT2 Receptor Antagonists
• N-(2-(3,4-Dichlorphenyl)ethyl)-N,N',N'-trimethyl-1,2-ethandiamin
• Methamphetamine
• volinanserin

Topics

• Animals
• Body Temperature (drug effects)
• Central Nervous System Stimulants (antagonists & inhibitors, toxicity)
• Electroencephalography (drug effects)
• Ethylenediamines (pharmacology)
• Fever (chemically induced, prevention & control)
• Fluorobenzenes (pharmacology)
• Lethal Dose 50
• Male
• Methamphetamine (antagonists & inhibitors, toxicity)
• Mice
• Piperidines (pharmacology)
• Receptors, sigma (antagonists & inhibitors)
• Seizures (chemically induced, prevention & control)
• Serotonin 5-HT2 Receptor Antagonists (pharmacology)
• Sigma-1 Receptor